Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-15
2000-02-01
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514336, 514438, 514461, 514473, 514604, 514708, 514741, 514764, 546142, 546153, 5462844, 549 78, 549475, 564 12, 564 90, 568 17, 568 34, C07D30762, A61K 31665
Patent
active
060203439
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5480568 (1996-01-01), Pawloski et al.
Belley Michel
Black Cameron
Gauthier Jacques Yves
Grimm Erich
Lau Cheuk-Kun
Billups Richard C
Davis Zinna Northington
Merck Frosst Canada Inc.
Rose David L.
LandOfFree
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-937788